2019 • 2018 • 2017 • 2016 • 2015 • 2014 • 2013 • 2012 • 2011 • 2010
2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000
— 2003 —
Ahmed SA, McPhie P, Smith LA. 2003. Autocatalytically fragmented light chain of botulinum A neurotoxins is enzymatically active. Biochemistry 42:12539-12549.
Aman MJ, Bosio CM, Burnett JC, Schmaljohn A, Bavari S. 2003. Molecular mechanisms of filovirus cellular trafficking. Microbes Infect 5:639-649.
Boles JW, Pitt ML, LeClaire RD, Gibbs PH, Torres E, Dyas B, Ulrich RG, Bavari S. 2003. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin Immunol 108:51-59.
Boles JW, Pitt MLM, LeClaire RD, Gibbs PH, Ulrich RG, Bavari S. 2003. Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule. Vaccine 11:2791-2796.
Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamazadeh M, Bavari S, Schmaljohn A. 2003. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 188:1630-1638.
Burnett JC, Schmidt JJ, Stafford RG, Panchal RG, Nguyen TL, Hermone AR, Vennerstrom JL, McGrath CH, Lane DL, Sausville EA, Zaharevitz DW, Gussio R, Bavari S. 2003. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochem Biophys Res Commun 310:84-93.
Carra JH, Welcher BC, Schokman RD, David CS, Bavari S. 2003. Mutational effects on protein folding stability and antigenicity: The case of streptococcal pyrogenic exotoxin A. Clin Immunol 108:60-68.
Cieslak TJ, Henretig FM. 2003. Bioterrorism. Pediatrics Ann 32:154-165.
Cuff L, Ulrich RG, Olson MA. 2003. Prediction of the multimeric assembly of staphylococcal enterotoxin A with cell-surface protein receptors. J Molec Graph Model 21:473-486.
Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. 2003. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77:9894-9905.
DaSilva L, Cote D, Roy C, Martinez M, Duniho S, Pitt ML, Downey T, Dertzbaugh M. 2003. Pulmonary gene expression profiling of inhaled ricin. Toxicon 41:813-822.
Dekonenko A, Yakimenko V, Ivanov A, Morozov V, Nikitin P, Khasanova S, Dzagurova T, Tkachenko E, Schmaljohn CS. 2003. Genetic similarity of Puumala viruses found in Finland and western Siberia and of the mitochondrial DNA of their rodent hosts suggests a common evolutionary origin. Infect Gen Evol 3:245-257.
Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163:2347-2370.
Geisbert TW, Jahrling PB. 2003. Towards a vaccine against Ebola virus. Exp Rev Vaccines 2:777-789.
Geisbert TW, AM Marty, Jahrling PB. 2003. Viral hemorrhagic fevers, pp 221-242, In MJ Roy (ed), Physician’s Guide to Terrorist Attack, Chapter 16, Human Press, Totowa NJ.
Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. 2003. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 188:1618-1629.
Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley L. 2003. Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163:2371-2382.
Guttieri MC, Liang M. 2003. Human antibody production using insect-cell expression systems, pp 269-299. In BKC Lo (ed), Methods in Molecular Biology, vol 248, Antibody Engineering: Methods and Protocols, Humana Press, Totowa NJ.
Guttieri MC, Sinha T, Bookwalter C, Liang M, Schmaljohn CS. 2003. Cassette vectors for conversion of Fab fragments into full-length human IgG1 monoclonal antibodies by expression in stably transformed insect cells. Hybridoma Hybridomics 22:135-145.
Hart MK. 2003. Vaccine research efforts for filoviruses. Int J Parasitol 33:583-595.
Hooper JW, Custer DM, Thompson E. 2003. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306:181-195.
Hurtle W, Bode E, Kaplan RS, Garrison J, Kearney B, Shoemaker D, Henchal E, Norwood D. 2003. Use of denaturing high-performance liquid chromatography to identify Bacillus anthracis by analysis of the 16S - 23S rRNA interspacer region and gyrA gene. J Clin Microbiol 41:4758-4766.
Hurtle W, Lindler L, Fan W, Shoemaker D, Henchal E, Norwood D. 2003. Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography. J Clin Microbiol 41:3273-3283.
Ibrahim MS, Kulesh DA, Saleh SS, Damon IK, Esposito JJ, Schmaljohn A, Jahrling PB. 2003. Real-time PCR assay to detect smallpox virus. J Clin Microbiol 41:3835-3839.
Jarrett CD. 2003. Lessons learned: The “pale horse” bioterrorism response exercise. Disaster Management Response 1:114-118
Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP. 2003. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71:584-587.
Jendrek S, Little SF, Hem S, Mitra G, Giardina S. 2003. Evaluation of the compatibility of a 2nd generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21:3011-3008.
Jensen MJ, Smith TJ, Ahmed SA, Smith LA. 2003. Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants. Toxicon 41:691-701.
Krakauer T. 2003. Measurement of proinflammatory cytokines and T-cell proliferative response in superantigen-activated human peripheral blood mononuclear cells. Methods Mol Biol 314:137-149.
Krakauer T, Buckley M. 2003. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Antimicrob Agents Chemother 47:3630-3633.
Krakauer T, Chen X, Howard OM, Young HA. 2003. RNAse protection assay for the study of the differential effects of therapeutic agents in suppressing staphylococcal enterotoxin B-induced cytokines in human peripheral blood mononuclear cells. Methods Mol Bio 314:151-164.
Krakauer T, Stiles BG. 2003. Staphylococcal enterotoxins, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: Some basic biology of bacterial superantigens. Recent Devel Infect Dis 1:1-27.
Lee JS, AG Hadjipanayis, SL Welkos. 2003. Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect Immun 71:1491-1496.
Marklund LA. 2003. Patient care in a biological safety level-4 (BSL-4) environment. Critical Care Nursing, Clinics of North America 15:245-255.
Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C. 2003. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 84:2197-2202.
Mellquist-Riemenschneider JL, Garrison AR, Geisbert JB, Heidebrink KD, Jahrling PB, Schmaljohn CS. 2003. Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for Ebola virus in guinea pigs. Virus Res 92:187-193.
Morrill JC, Peters CJ. 2003. Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 21:21-23.
Nalca A, Fellows PF, Whitehouse CA. 2003. Vaccines and animal models for arboviral encephalitides. Antivir Res 60:153-174.
Nelson EL, Prieto D, Alexander TG, Pushko P, Lofts LA, Rayner JO, Kamrud KI, Fralish B, Smith JF. 2003. Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model. Breast Canc Res Treat 82:169-183.
Poli MA. 2003. Foodborne marine biotoxins, pp 445-448. In MD Miliotis and JW Bier (ed) International Handbook on Foodborne Toxins, Marcel Dekker, Inc.
Pratt WD, Davis NL, Johnston RE, Smith JF. 2003. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: Testing in animal models. Vaccine 21:3854-3862.
Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81-86.
Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C. 2003. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 21:4071-4080.
Rivera VR, Merrill GA, White JA, Poli MA. 2003. An enzymatic electrochemiluminescence assay for the lethal factor of anthrax. Anal Biochem 321:125-130.
Roy CJ, Baker R, Washburn K, Bray M. 2003. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge. Antimicrob Agents Chemother 47:2933-2937.
Roy CJ, Hale M, Hartings J, Duniho S, Pitt L. 2003. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal Toxicol 15:619-638.
Roy CJ, Thorne PS. 2003. Exposure to particulates, microorganisms, b-(1-3)-glucans, and endotoxins during soybean harvesting. AIHA J 64:487-495.
Saikh KU, Dyas B, Kissner T, Ulrich RG. 2003. CD56+-T-cell responses to bacterial superantigens and immune recognition of attenuated vaccine. Clin Diag Lab Immunol 10:1065-1073.
Saikh KU, Lee JS, Kissner TL, Dyas B, Ulrich RG. 2003. Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J Infect Dis 188:1562-1570.
Sardelis MR, Turell MJ, Andre RG. 2003. Experimental transmission of St. Louis encephalitis virus by Ochlerotatus j japonicus. J Am Mosq Contr Asso 19:159-162.
Schmidt JJ, Stafford RG. 2003. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl Environ Microbiol 69:297-303.
Swietnicki W, Barnie AM, Dyas BK, Ulrich RG. 2003. Zinc binding and dimerization of Streptococcus pyogenes pyrogenic exotoxin C are not essential for T-cell stimulation. J Biol Chem 14:9885-9895.
Turell MJ, Bunning M, Ludwig GV, Ortman B, Chang J, Speaker T, Spielman A, McLean R, Komar N, Gates R, McNamara T, Creekmore T, Farley L, Mitchell CJ. 2003. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus). Emerg Infect Dis 9:1077-1081.
Turell MJ, O'Guinn ML, Navarro R, Estrada-Franco JG. 2003. Vector competence of Mexican and Honduran mosquitoes (Diptera:Culicidae) for enzootic (IE) and epizootic (IC) strains of Venezuelan equine encephalomyelitis virus. J Med Entomol 40:306-310.
Turell MJ, O'Guinn ML, Parker MD. 2003. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates. Am J Trop Med Hyg 68:218-221.
Turell MJ, O'Guinn ML, Wasieloski Jr LP, Lee, H-W Cho, Kim H-C, Burkett DA, Mores CN, Coleman RE, Klein TA. 2003. Isolation of Japanese encephalitis W-Jand Getah viruses from mosquitoes (Diptera: Culicidae) collected near Camp Greaves, Gyonggi Province, Republic of Korea, 2000. J Med Entomol 40:580-584.
Vogel P, Fritz DL. 2003. Cardiomyopathy associated with angiomatous pheochromocytoma in a rhesus macaque (Macaca mulatta). Vet Pathol 40:468-473.
Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S. 2003. Ebola virus-like particles protect from lethal Ebola infection. Proc Natl Acad Sci 10:1073.
Wasserman GM, Grabenstein JD, Pittman PR, Rubertone MV, Gibbs PP, Wang LX, Golder LGB. 2003. Analysis of adverse events after anthrax immunization in U.S. medical personnel. J Occup Environ Med 45:222-233.
|
SITEMAP
ARMY.MIL 
